AMAT vs ATRA · P/E 56, rev $24.04B vs rev $128.9M
Applied Materials Inc (AMAT) versus Atara Biotherapeutics Inc (ATRA) — a side-by-side from cached financials, not a winner call.
Applied Materials Inc (AMAT) is a semiconductor equipment & materials company listed on NASDAQ.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Latest reported AMAT revenue for 2026-07-26 was $24.04B. Net income was $7.37B. AMAT currently screens at market cap $470.75B and trailing P/E 55.8.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
AMAT currently screens at market cap $470.75B and trailing P/E 55.8. ATRA currently screens at market cap $87.1M.
Not investment advice. Open the AMAT and ATRA stock pages for the full models.
Not investment advice.